Search

Your search keyword '"Douwe F. Postma"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Douwe F. Postma" Remove constraint Author: "Douwe F. Postma"
35 results on '"Douwe F. Postma"'

Search Results

1. Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial

2. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

3. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

4. Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

5. Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol

6. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

7. Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

8. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial

9. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

10. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities

11. Risk factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant recipients: a multinational case-control study

12. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease

13. Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

14. Author response for 'Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients'

15. The value of open-source clinical science in pandemic response

16. Virale hepatitis: hoe zat het ook alweer?

17. Community-acquired pneumonia requiring hospitalization

18. Response Adjusted for Days of Antibiotic Risk (RADAR) : evaluation of a novel method to compare strategies to optimise antibiotic use

19. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

20. Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients

21. Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?

22. Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to analyze antibiotic stewardship interventions

23. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia : results from a cluster randomized cross-over trial

24. Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy

25. The Times They Are A-Changin’: Time-Dependent Exposures and Time-Dependent Confounders

26. Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia

27. Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults

28. Observed mortality reduction in patients hospitalized with community-acquired pneumonia may well be confounded by disease severity

29. The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review

30. Barriers to an early switch from Intravenous to oral antibiotic therapy in hospitalised patients with CAP

31. Effects of chlorhexidine oral decontamination on respiratory colonization during mechanical ventilation in intensive care unit patients

32. 668The Effectiveness of Beta-lactam Monotherapy, Beta-lactam and Macrolide Combination Therapy or Fluoroquinolone Monotherapy in Patients Hospitalized with Community-Acquired Pneumonia: a Cluster-Randomized Cross-Over Trial

33. Predicting Community-Acquired Pneumonia Etiology

34. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

35. Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia.

Catalog

Books, media, physical & digital resources